The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Two Listeria monocytogenes Vaccine Vectors That Express Different Molecular Forms of Human Papilloma Virus-16 (HPV-16) E7 Induce Qualitatively Different T Cell Immunity That Correlates with Their Ability to Induce Regression of Established Tumors Immortalized by HPV-16
Abstract
Two recombinant Listeria monocytogenes (rLm) strains were produced that secrete the human papilloma virus-16 (HPV-16) E7 protein expressed in HPV-16-associated cervical cancer cells. One, Lm-E7, expresses and secretes E7 protein, whereas a second, Lm-LLO-E7, secretes E7 as a fusion protein joined to a nonhemolytic listeriolysin O (LLO). Lm-LLO-E7, but not Lm-E7, induces the regression of the E7-expressing tumor, TC-1, established in syngeneic C57BL/6 mice. Both recombinant E7-expressing rLm vaccines induce measurable anti-E7 CTL responses that stain positively for H-2Db E7 tetramers. Depletion of the CD8+ T cell subset before treatment abrogates the ability of Lm-LLO-E7 to impact on tumor growth. In addition, the rLm strains induce markedly different CD4+ T cell subsets. Depletion of the CD4+ T cell subset considerably reduces the ability of Lm-LLO-E7 to eliminate established TC-1 tumors. Surprisingly, the reverse is the case for Lm-E7, which becomes an effective anti-tumor immunotherapeutic in mice lacking this T cell subset. Ab-mediated depletion of TGF-β and CD25+ cells improves the effectiveness of Lm-E7 treatment, suggesting that TGF-β and CD25+ cells are in part responsible for this suppressive response. CD4+ T cells from mice immunized with Lm-E7 are capable of suppressing the ability of Lm-LLO-E7 to induce the regression of TC-1 when transferred to tumor-bearing mice. These studies demonstrate the complexity of L. monocytogenes-mediated tumor immunotherapy targeting the human tumor Ag, HPV-16 E7.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
Read, S., Malmström, V., & Powrie, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.295 · Cited by 2,205
Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide
Jordan, M. S., Boesteanu, A., Reed, A. J., Petrone, A. L., Holenbeck, A. E., Lerman, M. A., Naji, A., & Caton, A. J. (2001) · Nature Immunology · doi:10.1038/86302 · Cited by 1,660
Itoh, M., Takahashi, T., Sakaguchi, N., Kuniyasu, Y., Shimizu, J., Otsuka, F., & Sakaguchi, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5317 · Cited by 1,211
Onizuka, S., Tawara, I., Shimizu, J., Sakaguchi, S., Fujita, T., & Nakayama, E. (1999) · PubMed · Cited by 1,062
Lin, K. Y., Guarnieri, F., Staveley-O’Carroll, K. F., Levitsky, H. I., August, J. T., Pardoll, D. M., & Wu, T. ‐. (1996) · PubMed · Cited by 1,003
Self-citationTHE INFLUENCE OF IMMUNOLOGICALLY COMMITTED LYMPHOID CELLS ON MACROPHAGE ACTIVITY IN VIVO
Mackaness, G. B. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.5.973 · Cited by 931
Feltkamp, M. C. W., Smits, H. L., Vierboom, M. P. M., Minnaar, R. P., De Jongh, B. M., Drijfhout, J. W., Schegget, J. T., Melief, C. J. M., & Kast, W. M. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230929 · Cited by 825
Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica
Herrero, R., Hildesheim, A., Bratti, C., Sherman, M. E., Hutchinson, M., Morales, J., Balmaceda, I., Greenberg, M. D., Alfaro, M., Burk, R. D., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.6.464 · Cited by 586
Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes
Pamer, E. G., Harty, J. T., & Bevan, M. J. (1991) · Nature · doi:10.1038/353852a0 · Cited by 417
Torre-Amione, G., Beauchamp, R. D., Koeppen, H., Park, B. H., Schreiber, H., Moses, H. L., & Rowley, D. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1486 · Cited by 403
Role of Listeriolysin O in Cell-to-Cell Spread of Listeria monocytogenes
Gedde, M. M., Higgins, D. E., Tilney, L. G., & Portnoy, D. A. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.999-1003.2000 · Cited by 253
Pan, Z.-K., Ikonomidis, G., Lazenby, A., Pardoll, D., & Paterson, Y. (1995) · Nature Medicine · doi:10.1038/nm0595-471 · Cited by 237
Self-citationHalbert, C. L., Demers, G. W., & Galloway, D. A. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2125-2134.1992 · Cited by 227
Beatty, G. L., & Paterson, Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2276 · Cited by 195
Self-citationBubert, A., Sokolovic, Z., Chun, S.-K., Papatheodorou, L., Simm, A., & Goebel, W. (1999) · Molecular and General Genetics MGG · doi:10.1007/s004380050973 · Cited by 175
Chu, N. R., Wu, H. B., Wu, T.-C., Boux, L. J., Siegel, M. I., & Mizzen, L. A. (2008) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2000.01293.x · Cited by 172
Self-citationPamer, E. G. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.2.686 · Cited by 157
Immunotherapy of human cancer: lessons from mice
Srivastava, P. K. (2000) · Nature Immunology · doi:10.1038/808795 · Cited by 138
Ikonomidis, G., Paterson, Y. Y. W., Kos, F. J., & Portnoy, D. A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.6.2209 · Cited by 132
Self-citationCuzick, J. M., Terry, G., Ho, L., Monaghan, J. M., Lopes, A. D. B., CLARKSON, P. K., & Duncan, I. D. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1103 · Cited by 123
Chang, H. L., Gillett, N. A., Figari, I. S., Lopez, A. R., Palladino, M. A., & Derynck, R. (1993) · PubMed · Cited by 113
Kanda, T., Watanabe, S., & Yoshiike, K. (1988) · Virology · doi:10.1016/0042-6822(88)90694-0 · Cited by 112
Mata, M., Travers, P. J., Liu, Q., Frankel, F. R., & Paterson, Y. Y. W. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2985 · Cited by 102
Self-citationPan, Z. K., Ikonomidis, G., Pardoll, D. M., & Paterson, Y. Y. W. (1995) · PubMed · Cited by 93
Self-citationRegression of established B16F10 melanoma with a recombinant Listeria monocytogenes vaccine.
Pan, Z.-K., Weiskirch, L. M., & Paterson, Y. Y. W. (1999) · PubMed · Cited by 92
Self-citationChen, C.-H., Ji, H., Suh, K., Choti, M. A., Pardoll, D. M., & Wu, T.-C. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301067 · Cited by 80
Self-citationRomanczuk, H., Villa, L. L., Schlegel, R., & Howley, P. M. (1991) · Journal of Virology · doi:10.1128/jvi.65.5.2739-2744.1991 · Cited by 77
Murine listeriosis as a model of antimicrobial defense
North, R. J., Dunn, P. L., & Conlan, J. W. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00989.x · Cited by 73
Mata, M., Yao, Z.-J., Zubair, A. C., Syres, K., & Paterson, Y. Y. W. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00379-0 · Cited by 56
Self-citationSijts, A. J. A. M., Pilip, I. M., & Pamer, E. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19261 · Cited by 53
Weiskirch, L. M., Pan, Z.-K., & Paterson, Y. Y. W. (2001) · Clinical Immunology · doi:10.1006/clim.2000.4987 · Cited by 18
Self-citation
Cited by
Tumour-targeting bacteria engineered to fight cancer
Zhou, S., Gravekamp, C., Bermudes, D., & Liu, K. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0070-z · Cited by 821
Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
Leventhal, D. S., Sokolovska, A., Li, N., Plescia, C., Kolodziej, S. A., Gallant, C. W., Christmas, R., Gao, J.-R., James, M. J., Abin-Fuentes, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16602-0 · Cited by 458
Engineering bacteria for diagnostic and therapeutic applications
Riglar, D. T., & Silver, P. A. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.172 · Cited by 460
Maciag, P. C., Radulovic, S., & Rothman, J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.041 · Cited by 324
Impact of Immunotherapy on CD4 T Cell Phenotypes and Function in Cancer
Saillard, M., Cenerenti, M., Romero, P., & Jandus, C. (2021) · Vaccines · doi:10.3390/vaccines9050454 · Cited by 23
Metadata
- Authors
- Gunn, G. R., Zubair, A., Peters, C., Pan, Z.-K., Wu, T.-C., & Paterson, Y.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-12-01
- Volume
- 167
- Issue
- 11
- Pages
- 6471-6479
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1831720205
- Cited by
- 298
- References
- 34
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.